Hostname: page-component-586b7cd67f-2brh9 Total loading time: 0 Render date: 2024-11-28T00:26:19.194Z Has data issue: false hasContentIssue false
  • English
  • Français

Ciprofloxacin and Clostridium difficile– Associated Diarrhea

Published online by Cambridge University Press:  02 January 2015

Claudia Thomas ,
Clayton L. Golledge  and
Thomas V. Riley
Claudia Thomas
Affiliation:
Departments of Microbiology and Public Health, University of Western Australia
Clayton L. Golledge
Affiliation:
Division of Microbiology and Infectious Diseases Western Australian Centre for Pathology and Medical Research
Thomas V. Riley
Affiliation:
Division of Microbiology and Infectious Diseases Western Australian Centre for Pathology and Medical Research Department of Microbiology, University of Western Australiaand Division of Microbiology and Infectious Diseases Western Australian Centre for Pathology and Medical Research Nedlands, Perth, Western Australia
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the Editor
Information
Infection Control & Hospital Epidemiology , Volume 23 , Issue 11 , November 2002 , pp. 637 - 638
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2002

References

1.Yip, C, Loeb, M, Salama, S, Moss, L, Olde, J. Quinolone use as a risk factor for nosocomial Clostridium difficile-associated diarrhea. Infect Control Hosp Epidemiol 2001;22:572–575.Google Scholar
2.Shah, S, Lewis, A, Leopold, D, Dunstan, F, Woodhouse, K. Gastric acid suppression does not promote clostridial diarrhoea in the elderly. QJM 2000;93:175–181.Google Scholar
3.Nath, SK, Salama, S, Persaud, D, et al. Drug risk factors associated with a sustained outbreak of Clostridium difficile diarrhea in a teaching hospital. Can J Infect Dis 1994;5:270–275.Google Scholar
4.Hutin, Y, Molina, JM, Casin, I, et al. Risk factors for Clostridium difficile-associated diarrhoea in HIV-infected patients. AIDS 1993;7:1441–1447.Google Scholar
5.Talon, D, Bailly, P, Delmee, M, et al. Use of pulsed-field gel electrophoresis for investigation of an outbreak of Clostridium difficile infection among geriatric patients. Eur J Clin Microbiol Infect Dis 1995;14:987–993.Google Scholar
6.Watanakunakorn, PW, Watanakunakorn, C, Hazy, J. Risk factors associated with Clostridium difficile diarrhea in hospitalized adult patients: a case-control study—sucralfate ingestion is not a negative risk factor. Infect Control Hosp Epidemiol 1996;17:232–235.Google Scholar
7.Halim, HA, Peterson, GM, Friesen, WT, Ott, AK. Case-controlled review of Clostridium difficile-associated diarrhoea in Southern Tasmania. J Clin Pharm Ther 1997;22:391–397.Google Scholar
8.Barbut, EMeynard, JL, Guiguet, M, et al. Clostridium difficile-associated diarrhea in HIV-infected patients: epidemiology and risk factors. J AIDS 1997;16:176–181.Google Scholar
9.Reeves, DS. The effect of quinolone antibacte-rials on the gastrointestinal flora compared with that of other antibacterials. J Antimicrob Chemother 1986;18:89–102.Google Scholar
10.Golledge, CL, Carson, CF, O'Neill, GL, Bowman, RA, Riley, TV. Ciprofloxacin and Clostridium difficile-associated diarrhoea. J Antimicrob Chemother 1992;30:141–147.Google Scholar
11.Bates, CJ, Wilcox, MH, Spencer, RC, Harris, DM. Ciprofloxacin and Clostridium difficile infection. Lancet 1990;336:1193.Google Scholar
12.Cain, DB, O'Connor, ME. Pseudomembranous colitis associated with ciprofloxacin. Lancet 1990:336:946.Google Scholar
13.Golledge, CL, O'Neill, GL, Carson, CF, Bowman, RA, Riley, TV. Ciprofloxacin and pseudomembranous colitis. Lancet 1990;336: 1509–1510.Google Scholar
14.McFarland, LV, Bauwens, JE, Melcher, SA, Surawicz, CM, Greenberg, RN, Elmer, GW. Ciprofloxacin-associated Clostridium difficile disease. Lancet 1995;346:977–978.Google Scholar